Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?

doi:10.1126/stke.3812007pe14

Account Information

Guest Alerts | Access Rights | My Account | Sign In

Site Navigation

Article Views

Article Tools

Help & Feedback

My Science Signaling

Sci. STKE, 10 April 2007
Vol. 2007, Issue 381, p. pe14
[DOI: 10.1126/stke.3812007pe14]

PERSPECTIVES

Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?

James G. Pan¹^* and Tak W. Mak²^*

¹Campbell Family Institute for Breast Cancer Research, University Health Network TMDT East Tower, MaRs Centre, 101 College Street, 5-705, Toronto, ON M5G 1L7, Canada.
²Campbell Family Institute for Breast Cancer Research, University Health Network and Departments of Medical Biophysics and Immunology, University of Toronto, 620 University Avenue, Suite 706, Toronto, ON, M5G 2C1, Canada.

Abstract: As a result of a spectrum of mitochondrial defects, tumor cells often preferentially use glycolysis to generate adenosine triphosphate (ATP), even in the presence of oxygen, a phenomenon known as aerobic glycolysis, or the "Warburg effect." Dichloroacetate (DCA) is an inhibitor of mitochondrial pyruvate dehydrogenase kinase (PDK), which inhibits pyruvate dehydrogenase (PDH), a gatekeeping enzyme for the entry of pyruvate into the mitochondrial tricarboxylic acid (TCA) cycle. In mice, DCA treatment appears to reactivate mitochondrial respiration in tumor cells, induces their selective killing, and suppresses cancer growth. These observations provide intriguing insights into the plasticity of tumor metabolism that may offer new opportunities for therapeutic intervention.

*To whom correspondence should be addressed. E-mail: tmak{at}uhnresearch.ca (T.W.M.); jpan{at}uhnres.utoronto.ca (J.G.P.)

Citation: J. G. Pan, T. W. Mak, Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era? Sci. STKE 2007, pe14 (2007).

Read the Full Text

The editors suggest the following Related Resources on Science sites:

In Science Signaling

EDITORS' CHOICE
Cancer
Pyruvate Kinase for Cancerous Metabolism: Nancy R. Gough (18 March 2008)
Sci. Signal. 1 (11), ec97. [DOI: 10.1126/stke.111ec97]
| Abstract »

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:

Dietary Energy Restriction Modulates the Activity of AMP-Activated Protein Kinase, Akt, and Mammalian Target of Rapamycin in Mammary Carcinomas, Mammary Gland, and Liver.: W. Jiang, Z. Zhu, and H. J. Thompson (2008)
Cancer Res. 68, 5492-5499
| Abstract » | Full Text » | PDF »

Laforin Confers Cancer Resistance to Energy Deprivation-Induced Apoptosis.: Y. Wang, Y. Liu, C. Wu, B. McNally, Y. Liu, and P. Zheng (2008)
Cancer Res. 68, 4039-4044
| Abstract » | Full Text » | PDF »